University Tech Transfer Offices: A Founder's Guide to Licensing Research

You have a result worth commercialising, a co-founder finishing a PhD, and a nagging suspicion that the hardest part is not the science. It rarely is. The step that stalls first-time academic founders is the paperwork that turns lab work into a licensable asset — and the office that controls it. University technology transfer offices are not obstacles to route around. They are counterparties, and the terms you agree in year one shape what you can raise, hire and sell in year five.

What a Technology Transfer Office Actually Does

A TTO exists to move research out of the lab and into use, and to return some of the value to the institution. In practice that means three jobs: collecting inventions from researchers, deciding how to protect them (usually patents, sometimes software copyright or deliberate trade secrecy), and licensing them — to an established company, or to a startup founded by the people who did the work.

Two things surprise founders. First, the office is staffed by people with portfolios, deadlines and internal politics, not by villains. Second, they are not your legal advisers; they represent the university's interests, and they will tell you so. You need your own counsel for the agreement itself.

Everything Starts With an Invention Disclosure

The formal relationship begins with a written disclosure: what was invented, by whom, with whose money, and what has already been said about it in public. File it before you publish or present if you possibly can. Public disclosure affects patent rights differently across jurisdictions, and it narrows your options everywhere.

A disclosure that moves quickly usually contains:

1. A plain-language description of the invention and the problem it solves, written for someone outside your field.
2. Inventors and their specific contributions. Inventorship is a legal question, not a thank-you list, and it is often disputed later.
3. Funding sources and grant numbers. Government and charitable funders usually attach obligations to the results.
4. Prior disclosures: abstracts, posters, thesis chapters, conference talks, preprints, even a departmental seminar.
5. Third-party materials and collaborations, including material transfer agreements and industry-sponsored work.
6. Your own intention. Say clearly that you want to start a company. Offices treat founder interest very differently from a vague hope that someone will license it.

Licence Terms That Decide Your Future

A spinout almost always needs an exclusive licence to the relevant patent family, because investors will not fund a company whose core asset anyone else can practise. Exclusivity is the headline; the details underneath are where deals are won and lost.

• Field of use. Ask for the field that matches your product, not "all therapeutic applications." A tighter field is easier to justify and easier to expand later.
• Retained rights. Universities keep the right to continue research and teaching. That is normal. Look instead for rights already promised to sponsors or collaborators.
• Upfront fees, equity and royalties. Founder-friendly licences often trade cash for a modest licence fee plus equity. Remember that equity is expensive currency: a few percent now is a few percent at exit.
• Milestones. Tie payments to financing rounds or regulatory steps rather than calendar dates. A payment due in month eighteen regardless of progress is a trap.
• Diligence obligations. "Commercially reasonable efforts" is workable. A fixed development schedule with termination for any deviation is not, unless you drafted it.
• Sublicensing and assignment. If you might partner with a larger company or be acquired, you need both rights in writing.
• Patent costs. Establish who pays prosecution costs, who instructs counsel, and what happens if you decide to abandon a patent.
• Termination and cure. You want a cure period for any alleged breach, and clarity on what survives termination.

Licence agreements are contracts with long tails. Have a lawyer who has negotiated university licences review anything before you sign it.

Negotiating without burning goodwill

TTO staff are repeat players, and you will deal with them again — for the next patent, the next licence, the next spinout. Come with a short business plan, a realistic development budget, and a clear ask. Do not request terms you cannot explain. Many offices will grant an option agreement: a few months of exclusivity while you incorporate, raise a first round and confirm the science. That is often more valuable than a discount on royalties.

Options and Spinout Timelines

Few of these steps run in parallel, so budget in months rather than weeks. The sequence is fairly consistent even when the speed is not:

• Disclosure submitted and reviewed; inventorship confirmed.
• Patent filing decision — often a provisional application to buy time.
• Option agreement signed while you incorporate and raise.
• Licence negotiation, usually running alongside fundraising.
• Founder agreements, equity split, and IP assignment from every inventor.
• Closing, then ongoing diligence and milestone reporting.

The most common delay is not the office. It is a founder who starts negotiating three months before the money runs out. Start the disclosure conversation while the research is still being written up.

The Paper Trail Nobody Warns You About

Before closing, every inventor needs to assign their rights to the new company, and every contributor needs to be accounted for: students, postdocs, visiting researchers, and anyone employed by another institution. Check whether an industry sponsor has a licence option on your results, and read the material transfer agreements that brought reagents or cell lines into the lab. Then handle the human side: conflict-of-interest declarations, a leave of absence policy, and the question of what role your principal investigator will hold. An unpaid advisory title and a real CSO position carry different obligations, and universities treat them differently.

Treat the Office as a Long-Term Partner

Pick one person at the office and keep them informed. Send short updates when a grant lands, when a paper is accepted, when a term sheet arrives. Ask for the university's standard licence template early, so you are negotiating from a known document rather than a blank page. When something goes wrong — a deadline missed, a milestone renegotiated — tell them before they find out. Institutions respond far better to founders who communicate than to founders who go quiet.

Your First Thirty Days

Write the disclosure. Tell your co-founders and your PI that you intend to start a company. Book a meeting with the TTO to ask what their process looks like, what the standard terms are, and how founder licensing has worked for others at your institution. Ask for introductions to two founders who have licensed from them recently, and ask those founders what they would negotiate differently. Then get a lawyer, and start drafting the plan the office will want to see. The science got you here; the paperwork decides whether you get to keep going.

Photo: Ludovic Delot / Pexels